3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Hematologic Diseases
1
Genital Neoplasms, Female
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma in Situ
1
Bone Marrow Diseases
1
Appendiceal Neoplasms
1
Anus Neoplasms
1
Interventions
Cyclophosphamide
23
fludarabine
14
Rituximab
14
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
Doxorubicin
7
pirtobrutinib
6
Vincristine
6
Prednisone
6
zanubrutinib
4
polatuzumab vedotin
4
obinutuzumab
4
Nivolumab
4
Etoposide
4
Dexamethasone
4
Biopsy
4
tazemetostat
3
tafasitamab
3
pembrolizumab
3
ibrutinib
3
glofitamab
3
fludarabine phosphate
3
acalabrutinib
3
Immunotherapy, Adoptive
3
Bendamustine Hydrochloride
3
venetoclax
2
pomalidomide
2
etoposide phosphate
2
cemiplimab
2
Prednisolone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Electrocardiography
×
90 days
×
Clear all
No trials found.